Industrial Pre-event: HealthAI & Digital Twins

Tapahtuman alkuperäinen kuvaus:

Ahead of the two-day MET Research Days event, the Industrial Pre-event will focus on data, AI, and digital twins for modeling healthcare processes and cost-effectiveness.

This event provides a unique opportunity to connect AI developers with pharma and life science companies, clinicians, and impact researchers, and to explore partnerships for P4 industry consortium projects.

The pre-event is organized by Business Tampere, the Faculty of Medicine and Health Technology, and the Tampere Health Ecosystem – an internationally connected, science-driven community at the forefront of P4 Medicine, leveraging New Approach Methodologies (NAM) and digital twins. The Tampere Health Ecosystem integrates innovative approaches, such as human organ-on-chip models and AI-based simulations, with testbed environments and real-world clinical data. This powerful combination accelerates drug discovery, improves translational relevance, and supports regulatory acceptance on the path to global markets.

Programme:

9:30-10:00 Morning coffee and networking

10:00-12:00 Health AI & Digital Twins Driving P4 Medicine

• Key Note: AI in Pharma and Life Sciences: From Industry Use to Impact, (TBC)
• Key Note: Digital Twins for Health and Pharma, (TBC)
• Digital Twin System as a new paradigm, case Diabetes care, Professor Frank Emmer-Streib, Tampere University and Chairman of the board Pekka Honkonen, HippocrAItes Oy
• Data-driven preventive and personalized cardiac health, Professor Juhana Frösen, Tampere University and CEO Sami Lakka, Lakka Health
• Digital Twins to model healthcare interventions cost-effectiveness, CEO Timo Erkkilä, Veracell
  

12:00-13:00 Lunch

13:00-14:00 Chip Twin for Faster and More Personalized Drug Development

• Key Note: Overview of biotech investment in Europe and biotech-pharma collaboration, 20min, General Manager Baedr Kayali, Abbvie Finland
• Key Note: Current and Future of NAMs in drug development – CRO perspective, General Manager Antti Nurmi, Charles River
• Building Better Tissues: The Role of Multi-Material Applications in Tissue Engineering and Regenerative Medicine, COO Paula Puistola, LifeGlue Technologies

14:00-14:30 Coffee

14:30-15:00

• Transforming Organ-on-Chip Research with Scalable Microenvironment Solutions, CEO Joose Kreutzer, Biogenium Microsystems
• Removing guesswork from cancer care with functional tumor-on-chip testing, CSO Heidi Haikala, Solid IO
  

15:10-15:45 Panel Discussion About Future Expectations

15:45-17:00 Snacks and networking

Join us to discuss, network, and discover new opportunities at the cutting edge of healthcare and medical research!